JP2018511622A5 - - Google Patents

Info

Publication number

JP2018511622A5

JP2018511622A5 JP2017553385A JP2017553385A JP2018511622A5 JP 2018511622 A5 JP2018511622 A5 JP 2018511622A5 JP 2017553385 A JP2017553385 A JP 2017553385A JP 2017553385 A JP2017553385 A JP 2017553385A JP 2018511622 A5 JP2018511622 A5 JP 2018511622A5

Authority

JP

Japan

Prior art keywords

tissue

poly

proteins

protein

peg

Prior art date

2016-04-12

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000002245 particle Substances 0.000 claims description 238
• 102000004169 proteins and genes Human genes 0.000 claims description 189
• 108090000623 proteins and genes Proteins 0.000 claims description 189
• 229920001223 polyethylene glycol Polymers 0.000 claims description 160
• 239000000203 mixture Substances 0.000 claims description 139
• 210000001519 tissue Anatomy 0.000 claims description 112
• -1 storage proteins Proteins 0.000 claims description 108
• 229940012952 fibrinogen Drugs 0.000 claims description 89
• 229920000642 polymer Polymers 0.000 claims description 84
• 108010049003 Fibrinogen Proteins 0.000 claims description 70
• 102000008946 Fibrinogen Human genes 0.000 claims description 70
• 210000004027 cell Anatomy 0.000 claims description 67
• 239000000499 gel Substances 0.000 claims description 65
• 229950003499 fibrin Drugs 0.000 claims description 64
• 239000003795 chemical substances by application Substances 0.000 claims description 61
• 239000002105 nanoparticle Substances 0.000 claims description 58
• 210000000130 stem cell Anatomy 0.000 claims description 55
• 239000003814 drug Substances 0.000 claims description 50
• VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims description 48
• 229940079593 drug Drugs 0.000 claims description 47
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
• 239000000243 solution Substances 0.000 claims description 43
• 108010073385 Fibrin Proteins 0.000 claims description 42
• 102000009123 Fibrin Human genes 0.000 claims description 42
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 40
• 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 36
• 238000000034 method Methods 0.000 claims description 36
• 239000000463 material Substances 0.000 claims description 34
• 239000000843 powder Substances 0.000 claims description 33
• 150000003839 salts Chemical class 0.000 claims description 28
• 210000003491 skin Anatomy 0.000 claims description 28
• 239000007787 solid Substances 0.000 claims description 28
• 230000006320 pegylation Effects 0.000 claims description 27
• 108010035532 Collagen Proteins 0.000 claims description 26
• 102000008186 Collagen Human genes 0.000 claims description 26
• 229920001436 collagen Polymers 0.000 claims description 26
• 108090000190 Thrombin Proteins 0.000 claims description 24
• 239000004599 antimicrobial Substances 0.000 claims description 24
• 229960004072 thrombin Drugs 0.000 claims description 24
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 23
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 23
• 210000002744 extracellular matrix Anatomy 0.000 claims description 23
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 23
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 23
• 238000003860 storage Methods 0.000 claims description 23
• 102000009027 Albumins Human genes 0.000 claims description 21
• 108010088751 Albumins Proteins 0.000 claims description 21
• 210000002381 plasma Anatomy 0.000 claims description 21
• 229920001282 polysaccharide Polymers 0.000 claims description 21
• 239000005017 polysaccharide Substances 0.000 claims description 21
• 239000012867 bioactive agent Substances 0.000 claims description 19
• 229920001222 biopolymer Polymers 0.000 claims description 19
• 150000004676 glycans Chemical class 0.000 claims description 19
• 210000002435 tendon Anatomy 0.000 claims description 18
• 238000004132 cross linking Methods 0.000 claims description 17
• 239000004005 microsphere Substances 0.000 claims description 17
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 15
• 239000002202 Polyethylene glycol Substances 0.000 claims description 14
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
• 229910052760 oxygen Inorganic materials 0.000 claims description 14
• 229920001184 polypeptide Polymers 0.000 claims description 14
• 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 13
• 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 13
• 239000003242 anti bacterial agent Substances 0.000 claims description 13
• 230000003115 biocidal effect Effects 0.000 claims description 13
• 239000003102 growth factor Substances 0.000 claims description 13
• 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 13
• 210000003205 muscle Anatomy 0.000 claims description 13
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 13
• 229920003169 water-soluble polymer Polymers 0.000 claims description 13
• 210000000845 cartilage Anatomy 0.000 claims description 12
• 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 11
• 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 11
• 229920002683 Glycosaminoglycan Polymers 0.000 claims description 11
• 229920002907 Guar gum Polymers 0.000 claims description 11
• 229920002125 Sokalan® Polymers 0.000 claims description 11
• 239000002246 antineoplastic agent Substances 0.000 claims description 11
• 239000012736 aqueous medium Substances 0.000 claims description 11
• 125000002091 cationic group Chemical group 0.000 claims description 11
• 238000000227 grinding Methods 0.000 claims description 11
• 235000010417 guar gum Nutrition 0.000 claims description 11
• 239000000665 guar gum Substances 0.000 claims description 11
• 229960002154 guar gum Drugs 0.000 claims description 11
• 229920002674 hyaluronan Polymers 0.000 claims description 11
• 108020004414 DNA Proteins 0.000 claims description 10
• 108090000288 Glycoproteins Proteins 0.000 claims description 10
• 102000003886 Glycoproteins Human genes 0.000 claims description 10
• 229940088710 antibiotic agent Drugs 0.000 claims description 10
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 10
• 230000036571 hydration Effects 0.000 claims description 10
• 238000006703 hydration reaction Methods 0.000 claims description 10
• 239000011859 microparticle Substances 0.000 claims description 10
• WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 10
• 229920002451 polyvinyl alcohol Polymers 0.000 claims description 10
• 229920001661 Chitosan Polymers 0.000 claims description 9
• 229920002307 Dextran Polymers 0.000 claims description 9
• 102000016942 Elastin Human genes 0.000 claims description 9
• 108010014258 Elastin Proteins 0.000 claims description 9
• 102000004190 Enzymes Human genes 0.000 claims description 9
• 108090000790 Enzymes Proteins 0.000 claims description 9
• 108010010803 Gelatin Proteins 0.000 claims description 9
• 108010085895 Laminin Proteins 0.000 claims description 9
• 102000007547 Laminin Human genes 0.000 claims description 9
• 229920001218 Pullulan Polymers 0.000 claims description 9
• 239000004373 Pullulan Substances 0.000 claims description 9
• 239000006143 cell culture medium Substances 0.000 claims description 9
• 229960002086 dextran Drugs 0.000 claims description 9
• 229920002549 elastin Polymers 0.000 claims description 9
• 229940088598 enzyme Drugs 0.000 claims description 9
• 239000008273 gelatin Substances 0.000 claims description 9
• 229920000159 gelatin Polymers 0.000 claims description 9
• 235000019322 gelatine Nutrition 0.000 claims description 9
• 235000011852 gelatine desserts Nutrition 0.000 claims description 9
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 9
• 235000019423 pullulan Nutrition 0.000 claims description 9
• 239000000341 volatile oil Substances 0.000 claims description 9
• SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 8
• NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
• 229940123208 Biguanide Drugs 0.000 claims description 8
• 229920001287 Chondroitin sulfate Polymers 0.000 claims description 8
• 102000015636 Oligopeptides Human genes 0.000 claims description 8
• 108010038807 Oligopeptides Proteins 0.000 claims description 8
• 230000000844 anti-bacterial effect Effects 0.000 claims description 8
• 229940041181 antineoplastic drug Drugs 0.000 claims description 8
• 239000007864 aqueous solution Substances 0.000 claims description 8
• 229940059329 chondroitin sulfate Drugs 0.000 claims description 8
• 229920001577 copolymer Polymers 0.000 claims description 8
• FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims description 8
• 239000002243 precursor Substances 0.000 claims description 8
• 230000002829 reductive effect Effects 0.000 claims description 8
• 239000007858 starting material Substances 0.000 claims description 8
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 7
• 241000283690 Bos taurus Species 0.000 claims description 7
• 108010076876 Keratins Proteins 0.000 claims description 7
• 102000011782 Keratins Human genes 0.000 claims description 7
• 239000003096 antiparasitic agent Substances 0.000 claims description 7
• 210000004204 blood vessel Anatomy 0.000 claims description 7
• 230000021164 cell adhesion Effects 0.000 claims description 7
• 210000005228 liver tissue Anatomy 0.000 claims description 7
• 239000002609 medium Substances 0.000 claims description 7
• 229920001285 xanthan gum Polymers 0.000 claims description 7
• LTMQZVLXCLQPCT-UHFFFAOYSA-N 1,1,6-trimethyltetralin Chemical compound C1CCC(C)(C)C=2C1=CC(C)=CC=2 LTMQZVLXCLQPCT-UHFFFAOYSA-N 0.000 claims description 6
• XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 claims description 6
• 102000004506 Blood Proteins Human genes 0.000 claims description 6
• 108010017384 Blood Proteins Proteins 0.000 claims description 6
• 229920000045 Dermatan sulfate Polymers 0.000 claims description 6
• 229920002148 Gellan gum Polymers 0.000 claims description 6
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 6
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 6
• 210000004381 amniotic fluid Anatomy 0.000 claims description 6
• 229940121375 antifungal agent Drugs 0.000 claims description 6
• 239000002220 antihypertensive agent Substances 0.000 claims description 6
• 229960005475 antiinfective agent Drugs 0.000 claims description 6
• 229940125687 antiparasitic agent Drugs 0.000 claims description 6
• 230000001588 bifunctional effect Effects 0.000 claims description 6
• 230000000975 bioactive effect Effects 0.000 claims description 6
• 229920002988 biodegradable polymer Polymers 0.000 claims description 6
• 239000004621 biodegradable polymer Substances 0.000 claims description 6
• 210000005068 bladder tissue Anatomy 0.000 claims description 6
• 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 6
• 210000001612 chondrocyte Anatomy 0.000 claims description 6
• 229960005188 collagen Drugs 0.000 claims description 6
• 239000003431 cross linking reagent Substances 0.000 claims description 6
• AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims description 6
• 229940051593 dermatan sulfate Drugs 0.000 claims description 6
• AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims description 6
• 235000010492 gellan gum Nutrition 0.000 claims description 6
• 239000000216 gellan gum Substances 0.000 claims description 6
• 210000005003 heart tissue Anatomy 0.000 claims description 6
• 235000012907 honey Nutrition 0.000 claims description 6
• 229940099552 hyaluronan Drugs 0.000 claims description 6
• KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 6
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 6
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 6
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 6
• 230000000968 intestinal effect Effects 0.000 claims description 6
• 210000004072 lung Anatomy 0.000 claims description 6
• 239000002073 nanorod Substances 0.000 claims description 6
• 239000002078 nanoshell Substances 0.000 claims description 6
• 210000000944 nerve tissue Anatomy 0.000 claims description 6
• 210000004923 pancreatic tissue Anatomy 0.000 claims description 6
• 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 claims description 6
• 210000005084 renal tissue Anatomy 0.000 claims description 6
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 6
• 210000001260 vocal cord Anatomy 0.000 claims description 6
• 235000010493 xanthan gum Nutrition 0.000 claims description 6
• 239000000230 xanthan gum Substances 0.000 claims description 6
• 229940082509 xanthan gum Drugs 0.000 claims description 6
• 108010078791 Carrier Proteins Proteins 0.000 claims description 5
• 102000014914 Carrier Proteins Human genes 0.000 claims description 5
• 108010067306 Fibronectins Proteins 0.000 claims description 5
• 102000016359 Fibronectins Human genes 0.000 claims description 5
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 5
• 229930182566 Gentamicin Natural products 0.000 claims description 5
• 108010089792 Hemeproteins Proteins 0.000 claims description 5
• 102000008015 Hemeproteins Human genes 0.000 claims description 5
• 108090000862 Ion Channels Proteins 0.000 claims description 5
• 102000004310 Ion Channels Human genes 0.000 claims description 5
• 108010052285 Membrane Proteins Proteins 0.000 claims description 5
• 108010063312 Metalloproteins Proteins 0.000 claims description 5
• 102000010750 Metalloproteins Human genes 0.000 claims description 5
• 102000005431 Molecular Chaperones Human genes 0.000 claims description 5
• 108010006519 Molecular Chaperones Proteins 0.000 claims description 5
• 108010089610 Nuclear Proteins Proteins 0.000 claims description 5
• 102000007999 Nuclear Proteins Human genes 0.000 claims description 5
• 102000016611 Proteoglycans Human genes 0.000 claims description 5
• 108010067787 Proteoglycans Proteins 0.000 claims description 5
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 5
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 5
• 108020004459 Small interfering RNA Proteins 0.000 claims description 5
• 101710172711 Structural protein Proteins 0.000 claims description 5
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 5
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 5
• 241000700605 Viruses Species 0.000 claims description 5
• LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 claims description 5
• 229950010221 alexidine Drugs 0.000 claims description 5
• 230000002421 anti-septic effect Effects 0.000 claims description 5
• 239000003429 antifungal agent Substances 0.000 claims description 5
• 210000004369 blood Anatomy 0.000 claims description 5
• 239000008280 blood Substances 0.000 claims description 5
• 230000015271 coagulation Effects 0.000 claims description 5
• 238000005345 coagulation Methods 0.000 claims description 5
• 230000007123 defense Effects 0.000 claims description 5
• 125000004386 diacrylate group Chemical group 0.000 claims description 5
• 102000034240 fibrous proteins Human genes 0.000 claims description 5
• 108091005899 fibrous proteins Proteins 0.000 claims description 5
• 239000012634 fragment Substances 0.000 claims description 5
• 102000034238 globular proteins Human genes 0.000 claims description 5
• 108091005896 globular proteins Proteins 0.000 claims description 5
• 239000000122 growth hormone Substances 0.000 claims description 5
• 229940088597 hormone Drugs 0.000 claims description 5
• 239000005556 hormone Substances 0.000 claims description 5
• 229960003160 hyaluronic acid Drugs 0.000 claims description 5
• 210000000987 immune system Anatomy 0.000 claims description 5
• 235000015110 jellies Nutrition 0.000 claims description 5
• 239000008274 jelly Substances 0.000 claims description 5
• KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 claims description 5
• 150000002632 lipids Chemical class 0.000 claims description 5
• 230000031787 nutrient reservoir activity Effects 0.000 claims description 5
• 235000015097 nutrients Nutrition 0.000 claims description 5
• 239000000813 peptide hormone Substances 0.000 claims description 5
• 102000005962 receptors Human genes 0.000 claims description 5
• 108020003175 receptors Proteins 0.000 claims description 5
• 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 4
• GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 4
• 102000002585 Contractile Proteins Human genes 0.000 claims description 4
• 108010068426 Contractile Proteins Proteins 0.000 claims description 4
• 102000004127 Cytokines Human genes 0.000 claims description 4
• 108090000695 Cytokines Proteins 0.000 claims description 4
• 229920002971 Heparan sulfate Polymers 0.000 claims description 4
• 229920000288 Keratan sulfate Polymers 0.000 claims description 4
• 240000003553 Leptospermum scoparium Species 0.000 claims description 4
• 108010093825 Mucoproteins Proteins 0.000 claims description 4
• 102000001621 Mucoproteins Human genes 0.000 claims description 4
• 206010028980 Neoplasm Diseases 0.000 claims description 4
• 108090000189 Neuropeptides Proteins 0.000 claims description 4
• 229920000954 Polyglycolide Polymers 0.000 claims description 4
• 229920002305 Schizophyllan Polymers 0.000 claims description 4
• 208000007536 Thrombosis Diseases 0.000 claims description 4
• 239000002253 acid Substances 0.000 claims description 4
• 239000000739 antihistaminic agent Substances 0.000 claims description 4
• 239000003904 antiprotozoal agent Substances 0.000 claims description 4
• 239000003443 antiviral agent Substances 0.000 claims description 4
• 229960000686 benzalkonium chloride Drugs 0.000 claims description 4
• UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 4
• 229960001950 benzethonium chloride Drugs 0.000 claims description 4
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 4
• 239000007853 buffer solution Substances 0.000 claims description 4
• 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 4
• 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
• 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 4
• 235000010418 carrageenan Nutrition 0.000 claims description 4
• 229920001525 carrageenan Polymers 0.000 claims description 4
• 239000000679 carrageenan Substances 0.000 claims description 4
• 229940113118 carrageenan Drugs 0.000 claims description 4
• 239000000919 ceramic Substances 0.000 claims description 4
• 229960003260 chlorhexidine Drugs 0.000 claims description 4
• 239000011557 critical solution Substances 0.000 claims description 4
• 230000004069 differentiation Effects 0.000 claims description 4
• GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 claims description 4
• 210000001671 embryonic stem cell Anatomy 0.000 claims description 4
• 239000003193 general anesthetic agent Substances 0.000 claims description 4
• 230000028993 immune response Effects 0.000 claims description 4
• 102000006495 integrins Human genes 0.000 claims description 4
• 108010044426 integrins Proteins 0.000 claims description 4
• 239000002502 liposome Substances 0.000 claims description 4
• 229920000609 methyl cellulose Polymers 0.000 claims description 4
• 235000010981 methylcellulose Nutrition 0.000 claims description 4
• 239000001923 methylcellulose Substances 0.000 claims description 4
• 230000007935 neutral effect Effects 0.000 claims description 4
• 108020004707 nucleic acids Proteins 0.000 claims description 4
• 102000039446 nucleic acids Human genes 0.000 claims description 4
• 150000007523 nucleic acids Chemical class 0.000 claims description 4
• 208000033808 peripheral neuropathy Diseases 0.000 claims description 4
• 150000003904 phospholipids Chemical class 0.000 claims description 4
• 210000005059 placental tissue Anatomy 0.000 claims description 4
• 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 claims description 4
• 229920000747 poly(lactic acid) Polymers 0.000 claims description 4
• 229920001610 polycaprolactone Polymers 0.000 claims description 4
• 239000004632 polycaprolactone Substances 0.000 claims description 4
• 229920000728 polyester Polymers 0.000 claims description 4
• 210000002966 serum Anatomy 0.000 claims description 4
• 238000010008 shearing Methods 0.000 claims description 4
• 108091006024 signal transducing proteins Proteins 0.000 claims description 4
• 102000034285 signal transducing proteins Human genes 0.000 claims description 4
• 230000003330 sporicidal effect Effects 0.000 claims description 4
• 210000002536 stromal cell Anatomy 0.000 claims description 4
• 230000000699 topical effect Effects 0.000 claims description 4
• 239000011782 vitamin Substances 0.000 claims description 4
• 229940088594 vitamin Drugs 0.000 claims description 4
• 235000013343 vitamin Nutrition 0.000 claims description 4
• 229930003231 vitamin Natural products 0.000 claims description 4
• UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 4
• SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 3
• XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims description 3
• WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 claims description 3
• MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 claims description 3
• LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 claims description 3
• JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 claims description 3
• CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 claims description 3
• ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 claims description 3
• VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 3
• QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 claims description 3
• XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 claims description 3
• SPHKINBTXPIQTH-UHFFFAOYSA-N 2H-benzotriazol-4-yl hydrogen carbonate Chemical compound OC(=O)OC1=CC=CC2=NNN=C12 SPHKINBTXPIQTH-UHFFFAOYSA-N 0.000 claims description 3
• 229930000680 A04AD01 - Scopolamine Natural products 0.000 claims description 3
• 244000215068 Acacia senegal Species 0.000 claims description 3
• HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 3
• 241001430066 Anulocaulis Species 0.000 claims description 3
• 108010001478 Bacitracin Proteins 0.000 claims description 3
• 239000004342 Benzoyl peroxide Substances 0.000 claims description 3
• OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 3
• GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 3
• GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 claims description 3
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 3
• 229910052688 Gadolinium Inorganic materials 0.000 claims description 3
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 3
• 229930186217 Glycolipid Natural products 0.000 claims description 3
• 229920000084 Gum arabic Polymers 0.000 claims description 3
• 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 3
• 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 3
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
• STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 claims description 3
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 claims description 3
• 102000004877 Insulin Human genes 0.000 claims description 3
• 108090001061 Insulin Proteins 0.000 claims description 3
• ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 3
• 235000016887 Leptospermum scoparium Nutrition 0.000 claims description 3
• 229920000161 Locust bean gum Polymers 0.000 claims description 3
• 229930192392 Mitomycin Natural products 0.000 claims description 3
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims description 3
• STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 claims description 3
• SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 claims description 3
• 239000000006 Nitroglycerin Substances 0.000 claims description 3
• 229920001145 Poly(N-vinylacetamide) Polymers 0.000 claims description 3
• 229920002845 Poly(methacrylic acid) Polymers 0.000 claims description 3
• 229920002732 Polyanhydride Polymers 0.000 claims description 3
• 108010093965 Polymyxin B Proteins 0.000 claims description 3
• 229920000153 Povidone-iodine Polymers 0.000 claims description 3
• 108091008103 RNA aptamers Proteins 0.000 claims description 3
• 240000004584 Tamarindus indica Species 0.000 claims description 3
• 235000004298 Tamarindus indica Nutrition 0.000 claims description 3
• 239000004098 Tetracycline Substances 0.000 claims description 3
• 235000010489 acacia gum Nutrition 0.000 claims description 3
• 239000000205 acacia gum Substances 0.000 claims description 3
• 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims description 3
• 210000001789 adipocyte Anatomy 0.000 claims description 3
• 210000004504 adult stem cell Anatomy 0.000 claims description 3
• 229940061720 alpha hydroxy acid Drugs 0.000 claims description 3
• 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 3
• 230000000954 anitussive effect Effects 0.000 claims description 3
• 239000000730 antalgic agent Substances 0.000 claims description 3
• 229940045799 anthracyclines and related substance Drugs 0.000 claims description 3
• 230000003712 anti-aging effect Effects 0.000 claims description 3
• 230000002280 anti-androgenic effect Effects 0.000 claims description 3
• 239000004004 anti-anginal agent Substances 0.000 claims description 3
• 230000001166 anti-perspirative effect Effects 0.000 claims description 3
• 239000000043 antiallergic agent Substances 0.000 claims description 3
• 239000000051 antiandrogen Substances 0.000 claims description 3
• 239000003416 antiarrhythmic agent Substances 0.000 claims description 3
• 239000003146 anticoagulant agent Substances 0.000 claims description 3
• 229940127219 anticoagulant drug Drugs 0.000 claims description 3
• 239000001961 anticonvulsive agent Substances 0.000 claims description 3
• 239000000935 antidepressant agent Substances 0.000 claims description 3
• 229940005513 antidepressants Drugs 0.000 claims description 3
• 239000002111 antiemetic agent Substances 0.000 claims description 3
• 229940030600 antihypertensive agent Drugs 0.000 claims description 3
• 229940127088 antihypertensive drug Drugs 0.000 claims description 3
• 239000003430 antimalarial agent Substances 0.000 claims description 3
• 239000003213 antiperspirant Substances 0.000 claims description 3
• 239000003435 antirheumatic agent Substances 0.000 claims description 3
• 239000000074 antisense oligonucleotide Substances 0.000 claims description 3
• 238000012230 antisense oligonucleotides Methods 0.000 claims description 3
• 229940124584 antitussives Drugs 0.000 claims description 3
• 230000006907 apoptotic process Effects 0.000 claims description 3
• 210000001130 astrocyte Anatomy 0.000 claims description 3
• 229960003071 bacitracin Drugs 0.000 claims description 3
• 229930184125 bacitracin Natural products 0.000 claims description 3
• CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 claims description 3
• 230000001580 bacterial effect Effects 0.000 claims description 3
• 239000003855 balanced salt solution Substances 0.000 claims description 3
• 229960003328 benzoyl peroxide Drugs 0.000 claims description 3
• 235000019400 benzoyl peroxide Nutrition 0.000 claims description 3
• ACBQROXDOHKANW-UHFFFAOYSA-N bis(4-nitrophenyl) carbonate Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC(=O)OC1=CC=C([N+]([O-])=O)C=C1 ACBQROXDOHKANW-UHFFFAOYSA-N 0.000 claims description 3
• 229910052797 bismuth Inorganic materials 0.000 claims description 3
• JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 3
• 238000012661 block copolymerization Methods 0.000 claims description 3
• 210000001772 blood platelet Anatomy 0.000 claims description 3
• 210000001185 bone marrow Anatomy 0.000 claims description 3
• 210000002798 bone marrow cell Anatomy 0.000 claims description 3
• 229960003150 bupivacaine Drugs 0.000 claims description 3
• RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 claims description 3
• 229960001736 buprenorphine Drugs 0.000 claims description 3
• 229930003827 cannabinoid Natural products 0.000 claims description 3
• 239000003557 cannabinoid Substances 0.000 claims description 3
• 229960001631 carbomer Drugs 0.000 claims description 3
• 230000000747 cardiac effect Effects 0.000 claims description 3
• 239000002327 cardiovascular agent Substances 0.000 claims description 3
• 239000003518 caustics Substances 0.000 claims description 3
• 239000002738 chelating agent Substances 0.000 claims description 3
• 230000003399 chemotactic effect Effects 0.000 claims description 3
• 229960002896 clonidine Drugs 0.000 claims description 3
• 229960004022 clotrimazole Drugs 0.000 claims description 3
• VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims description 3
• 239000003433 contraceptive agent Substances 0.000 claims description 3
• 239000003246 corticosteroid Substances 0.000 claims description 3
• 229960001334 corticosteroids Drugs 0.000 claims description 3
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
• 239000000412 dendrimer Substances 0.000 claims description 3
• 229920000736 dendritic polymer Polymers 0.000 claims description 3
• 229960000633 dextran sulfate Drugs 0.000 claims description 3
• 229960001259 diclofenac Drugs 0.000 claims description 3
• DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims description 3
• YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 claims description 3
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims description 3
• 230000002526 effect on cardiovascular system Effects 0.000 claims description 3
• 230000002124 endocrine Effects 0.000 claims description 3
• 210000002889 endothelial cell Anatomy 0.000 claims description 3
• 230000003511 endothelial effect Effects 0.000 claims description 3
• 239000002532 enzyme inhibitor Substances 0.000 claims description 3
• 210000002514 epidermal stem cell Anatomy 0.000 claims description 3
• 210000002919 epithelial cell Anatomy 0.000 claims description 3
• 229960005309 estradiol Drugs 0.000 claims description 3
• 229930182833 estradiol Natural products 0.000 claims description 3
• BNKAXGCRDYRABM-UHFFFAOYSA-N ethenyl dihydrogen phosphate Chemical class OP(O)(=O)OC=C BNKAXGCRDYRABM-UHFFFAOYSA-N 0.000 claims description 3
• 210000004700 fetal blood Anatomy 0.000 claims description 3
• 210000002950 fibroblast Anatomy 0.000 claims description 3
• 229960002949 fluorouracil Drugs 0.000 claims description 3
• PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 claims description 3
• UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims description 3
• 210000001654 germ layer Anatomy 0.000 claims description 3
• 229960003711 glyceryl trinitrate Drugs 0.000 claims description 3
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
• 239000010931 gold Substances 0.000 claims description 3
• 229910052737 gold Inorganic materials 0.000 claims description 3
• 239000003163 gonadal steroid hormone Substances 0.000 claims description 3
• 239000007952 growth promoter Substances 0.000 claims description 3
• 230000003779 hair growth Effects 0.000 claims description 3
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
• 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 3
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
• 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
• 239000002955 immunomodulating agent Substances 0.000 claims description 3
• 229940121354 immunomodulator Drugs 0.000 claims description 3
• 210000004263 induced pluripotent stem cell Anatomy 0.000 claims description 3
• 239000000411 inducer Substances 0.000 claims description 3
• 229940125396 insulin Drugs 0.000 claims description 3
• 210000002490 intestinal epithelial cell Anatomy 0.000 claims description 3
• 125000002346 iodo group Chemical group I* 0.000 claims description 3
• CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 3
• 235000008696 isoflavones Nutrition 0.000 claims description 3
• 210000002510 keratinocyte Anatomy 0.000 claims description 3
• 229960004125 ketoconazole Drugs 0.000 claims description 3
• DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims description 3
• 229960000991 ketoprofen Drugs 0.000 claims description 3
• 239000003446 ligand Substances 0.000 claims description 3
• 235000010420 locust bean gum Nutrition 0.000 claims description 3
• 239000000711 locust bean gum Substances 0.000 claims description 3
• 210000004698 lymphocyte Anatomy 0.000 claims description 3
• 206010025482 malaise Diseases 0.000 claims description 3
• 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 3
• 239000002082 metal nanoparticle Substances 0.000 claims description 3
• 239000000693 micelle Substances 0.000 claims description 3
• 229960005040 miconazole nitrate Drugs 0.000 claims description 3
• 229960004857 mitomycin Drugs 0.000 claims description 3
• 239000003607 modifier Substances 0.000 claims description 3
• 150000002772 monosaccharides Chemical class 0.000 claims description 3
• 210000003098 myoblast Anatomy 0.000 claims description 3
• 210000000107 myocyte Anatomy 0.000 claims description 3
• HOHCIWOKFBMYLM-UHFFFAOYSA-N n,n-dimethylmethanamine;2-methylprop-2-enamide Chemical compound CN(C)C.CC(=C)C(N)=O HOHCIWOKFBMYLM-UHFFFAOYSA-N 0.000 claims description 3
• ZQXSMRAEXCEDJD-UHFFFAOYSA-N n-ethenylformamide Chemical compound C=CNC=O ZQXSMRAEXCEDJD-UHFFFAOYSA-N 0.000 claims description 3
• 229940031182 nanoparticles iron oxide Drugs 0.000 claims description 3
• 239000003887 narcotic antagonist Substances 0.000 claims description 3
• 229940053050 neomycin sulfate Drugs 0.000 claims description 3
• 210000001178 neural stem cell Anatomy 0.000 claims description 3
• 210000004498 neuroglial cell Anatomy 0.000 claims description 3
• 210000002569 neuron Anatomy 0.000 claims description 3
• 210000000440 neutrophil Anatomy 0.000 claims description 3
• 229960002715 nicotine Drugs 0.000 claims description 3
• SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 3
• 229960003512 nicotinic acid Drugs 0.000 claims description 3
• 235000001968 nicotinic acid Nutrition 0.000 claims description 3
• 239000011664 nicotinic acid Substances 0.000 claims description 3
• IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 claims description 3
• 229960001907 nitrofurazone Drugs 0.000 claims description 3
• 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 3
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 3
• RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 claims description 3
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 3
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 3
• 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 3
• 230000009984 peri-natal effect Effects 0.000 claims description 3
• 210000003668 pericyte Anatomy 0.000 claims description 3
• 239000013612 plasmid Substances 0.000 claims description 3
• 210000001778 pluripotent stem cell Anatomy 0.000 claims description 3
• 229920002939 poly(N,N-dimethylacrylamides) Polymers 0.000 claims description 3
• 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 claims description 3
• 229920001308 poly(aminoacid) Polymers 0.000 claims description 3
• 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 3
• 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims description 3
• 229920002627 poly(phosphazenes) Polymers 0.000 claims description 3
• 229920002401 polyacrylamide Polymers 0.000 claims description 3
• 239000000622 polydioxanone Substances 0.000 claims description 3
• 150000004291 polyenes Chemical class 0.000 claims description 3
• 229920000024 polymyxin B Polymers 0.000 claims description 3
• 229960005266 polymyxin b Drugs 0.000 claims description 3
• 239000003910 polypeptide antibiotic agent Substances 0.000 claims description 3
• 229920001299 polypropylene fumarate Polymers 0.000 claims description 3
• 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 3
• 229920002635 polyurethane Polymers 0.000 claims description 3
• 239000004814 polyurethane Substances 0.000 claims description 3
• 229960001621 povidone-iodine Drugs 0.000 claims description 3
• 229940002612 prodrug Drugs 0.000 claims description 3
• 239000000651 prodrug Substances 0.000 claims description 3
• JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims description 3
• 239000002096 quantum dot Substances 0.000 claims description 3
• 239000010453 quartz Substances 0.000 claims description 3
• 229960004889 salicylic acid Drugs 0.000 claims description 3
• 210000004116 schwann cell Anatomy 0.000 claims description 3
• 229960002646 scopolamine Drugs 0.000 claims description 3
• STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 claims description 3
• 210000001646 side-population cell Anatomy 0.000 claims description 3
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
• 150000003378 silver Chemical class 0.000 claims description 3
• 229960003600 silver sulfadiazine Drugs 0.000 claims description 3
• UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 claims description 3
• 210000001057 smooth muscle myoblast Anatomy 0.000 claims description 3
• 210000000329 smooth muscle myocyte Anatomy 0.000 claims description 3
• 239000011734 sodium Substances 0.000 claims description 3
• 229910052708 sodium Inorganic materials 0.000 claims description 3
• 210000003594 spinal ganglia Anatomy 0.000 claims description 3
• 150000003431 steroids Chemical class 0.000 claims description 3
• 229960003604 testosterone Drugs 0.000 claims description 3
• 229960002180 tetracycline Drugs 0.000 claims description 3
• 229930101283 tetracycline Natural products 0.000 claims description 3
• 235000019364 tetracycline Nutrition 0.000 claims description 3
• 150000003522 tetracyclines Chemical class 0.000 claims description 3
• 210000003014 totipotent stem cell Anatomy 0.000 claims description 3
• 238000001890 transfection Methods 0.000 claims description 3
• 210000002444 unipotent stem cell Anatomy 0.000 claims description 3
• 239000005526 vasoconstrictor agent Substances 0.000 claims description 3
• 229940124549 vasodilator Drugs 0.000 claims description 3
• 239000003071 vasodilator agent Substances 0.000 claims description 3
• NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical class OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 claims description 3
• 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
• 150000003751 zinc Chemical class 0.000 claims description 3
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 2
• BRJJFBHTDVWTCJ-UHFFFAOYSA-N 1-[n'-[6-[[amino-[[n'-(2-ethylhexyl)carbamimidoyl]amino]methylidene]amino]hexyl]carbamimidoyl]-2-(2-ethylhexyl)guanidine;dihydrochloride Chemical compound Cl.Cl.CCCCC(CC)CN=C(N)NC(N)=NCCCCCCN=C(N)NC(N)=NCC(CC)CCCC BRJJFBHTDVWTCJ-UHFFFAOYSA-N 0.000 claims description 2
• VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 claims description 2
• DMKKMGYBLFUGTO-UHFFFAOYSA-N 2-methyloxirane;oxirane Chemical compound C1CO1.C1CO1.CC1CO1 DMKKMGYBLFUGTO-UHFFFAOYSA-N 0.000 claims description 2
• 235000002961 Aloe barbadensis Nutrition 0.000 claims description 2
• 244000144927 Aloe barbadensis Species 0.000 claims description 2
• 108010085220 Multiprotein Complexes Proteins 0.000 claims description 2
• 102000007474 Multiprotein Complexes Human genes 0.000 claims description 2
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
• 229920000289 Polyquaternium Polymers 0.000 claims description 2
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
• 150000007513 acids Chemical class 0.000 claims description 2
• 235000011399 aloe vera Nutrition 0.000 claims description 2
• 210000003663 amniotic stem cell Anatomy 0.000 claims description 2
• 229940035676 analgesics Drugs 0.000 claims description 2
• 230000003255 anti-acne Effects 0.000 claims description 2
• 230000003474 anti-emetic effect Effects 0.000 claims description 2
• 230000002682 anti-psoriatic effect Effects 0.000 claims description 2
• 229940125681 anticonvulsant agent Drugs 0.000 claims description 2
• 229940125683 antiemetic agent Drugs 0.000 claims description 2
• 229940030225 antihemorrhagics Drugs 0.000 claims description 2
• 229940030999 antipsoriatics Drugs 0.000 claims description 2
• 239000003576 central nervous system agent Substances 0.000 claims description 2
• WDRFFJWBUDTUCA-UHFFFAOYSA-N chlorhexidine acetate Chemical compound CC(O)=O.CC(O)=O.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WDRFFJWBUDTUCA-UHFFFAOYSA-N 0.000 claims description 2
• 229960001884 chlorhexidine diacetate Drugs 0.000 claims description 2
• 229940124558 contraceptive agent Drugs 0.000 claims description 2
• 230000018044 dehydration Effects 0.000 claims description 2
• 238000006297 dehydration reaction Methods 0.000 claims description 2
• 239000000645 desinfectant Substances 0.000 claims description 2
• PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 claims description 2
• 239000003974 emollient agent Substances 0.000 claims description 2
• SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims description 2
• 229960002428 fentanyl Drugs 0.000 claims description 2
• IVLVTNPOHDFFCJ-UHFFFAOYSA-N fentanyl citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 IVLVTNPOHDFFCJ-UHFFFAOYSA-N 0.000 claims description 2
• 210000000604 fetal stem cell Anatomy 0.000 claims description 2
• 239000002874 hemostatic agent Substances 0.000 claims description 2
• 210000003494 hepatocyte Anatomy 0.000 claims description 2
• 210000000936 intestine Anatomy 0.000 claims description 2
• 229960004130 itraconazole Drugs 0.000 claims description 2
• 210000001074 muscle attachment cell Anatomy 0.000 claims description 2
• 210000004165 myocardium Anatomy 0.000 claims description 2
• 201000001119 neuropathy Diseases 0.000 claims description 2
• 230000007823 neuropathy Effects 0.000 claims description 2
• 230000001734 parasympathetic effect Effects 0.000 claims description 2
• 229910052698 phosphorus Inorganic materials 0.000 claims description 2
• 239000011574 phosphorus Substances 0.000 claims description 2
• 229910052709 silver Inorganic materials 0.000 claims description 2
• 239000004332 silver Substances 0.000 claims description 2
• GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 2
• DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims description 2
• 229960000699 terbinafine hydrochloride Drugs 0.000 claims description 2
• 244000303965 Cyamopsis psoralioides Species 0.000 claims 6
• 230000001139 anti-pruritic effect Effects 0.000 claims 2
• 229940124623 antihistamine drug Drugs 0.000 claims 2
• 239000003908 antipruritic agent Substances 0.000 claims 2
• RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 claims 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 claims 1
• 102000018997 Growth Hormone Human genes 0.000 claims 1
• 108010051696 Growth Hormone Proteins 0.000 claims 1
• TYMRLRRVMHJFTF-UHFFFAOYSA-N Mafenide Chemical compound NCC1=CC=C(S(N)(=O)=O)C=C1 TYMRLRRVMHJFTF-UHFFFAOYSA-N 0.000 claims 1
• HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 claims 1
• 229920001710 Polyorthoester Polymers 0.000 claims 1
• 229940035674 anesthetics Drugs 0.000 claims 1
• 230000003288 anthiarrhythmic effect Effects 0.000 claims 1
• 230000001430 anti-depressive effect Effects 0.000 claims 1
• 230000003178 anti-diabetic effect Effects 0.000 claims 1
• 230000000843 anti-fungal effect Effects 0.000 claims 1
• 229940124599 anti-inflammatory drug Drugs 0.000 claims 1
• 230000000118 anti-neoplastic effect Effects 0.000 claims 1
• 229940033495 antimalarials Drugs 0.000 claims 1
• 229940034982 antineoplastic agent Drugs 0.000 claims 1
• 229960001231 choline Drugs 0.000 claims 1
• 231100001010 corrosive Toxicity 0.000 claims 1
• 229940000033 dermatological agent Drugs 0.000 claims 1
• 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
• 230000002584 immunomodulator Effects 0.000 claims 1
• GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims 1
• 229960003640 mafenide Drugs 0.000 claims 1
• 150000002759 monoacylglycerols Chemical class 0.000 claims 1
• 239000002745 poly(ortho ester) Substances 0.000 claims 1
• 230000000391 smoking effect Effects 0.000 claims 1
• 235000018102 proteins Nutrition 0.000 description 168
• 239000000017 hydrogel Substances 0.000 description 56
• 208000027418 Wounds and injury Diseases 0.000 description 39
• 206010052428 Wound Diseases 0.000 description 37
• 239000012530 fluid Substances 0.000 description 26
• 239000011159 matrix material Substances 0.000 description 25
• 238000002347 injection Methods 0.000 description 24
• 239000007924 injection Substances 0.000 description 24
• 239000002953 phosphate buffered saline Substances 0.000 description 20
• 210000004872 soft tissue Anatomy 0.000 description 18
• 238000002360 preparation method Methods 0.000 description 16
• 230000033115 angiogenesis Effects 0.000 description 14
• 230000008439 repair process Effects 0.000 description 13
• 239000000126 substance Substances 0.000 description 13
• 239000011800 void material Substances 0.000 description 13
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
• 230000015572 biosynthetic process Effects 0.000 description 12
• 230000012010 growth Effects 0.000 description 12
• 229940071826 hydroxyethyl cellulose Drugs 0.000 description 12
• 239000007788 liquid Substances 0.000 description 12
• 244000007835 Cyamopsis tetragonoloba Species 0.000 description 11
• 238000000576 coating method Methods 0.000 description 11
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 11
• 125000000524 functional group Chemical group 0.000 description 11
• 238000011065 in-situ storage Methods 0.000 description 11
• 241000700159 Rattus Species 0.000 description 10
• 230000000845 anti-microbial effect Effects 0.000 description 10
• 238000001802 infusion Methods 0.000 description 10
• 239000004570 mortar (masonry) Substances 0.000 description 10
• 239000011148 porous material Substances 0.000 description 10
• 238000006243 chemical reaction Methods 0.000 description 9
• 239000011248 coating agent Substances 0.000 description 9
• 239000000839 emulsion Substances 0.000 description 9
• 210000000056 organ Anatomy 0.000 description 9
• 239000011780 sodium chloride Substances 0.000 description 9
• 239000000725 suspension Substances 0.000 description 9
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
• 239000011575 calcium Substances 0.000 description 8
• 229910052791 calcium Inorganic materials 0.000 description 8
• 244000005700 microbiome Species 0.000 description 8
• 230000008569 process Effects 0.000 description 8
• 238000007920 subcutaneous administration Methods 0.000 description 8
• 229920001059 synthetic polymer Polymers 0.000 description 8
• 230000017423 tissue regeneration Effects 0.000 description 8
• 239000003981 vehicle Substances 0.000 description 8
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 7
• 241001662443 Phemeranthus parviflorus Species 0.000 description 7
• 229920002413 Polyhexanide Polymers 0.000 description 7
• 210000001691 amnion Anatomy 0.000 description 7
• 230000007547 defect Effects 0.000 description 7
• 230000006870 function Effects 0.000 description 7
• 230000001965 increasing effect Effects 0.000 description 7
• 238000007912 intraperitoneal administration Methods 0.000 description 7
• 239000011777 magnesium Substances 0.000 description 7
• 229910052749 magnesium Inorganic materials 0.000 description 7
• 235000004252 protein component Nutrition 0.000 description 7
• 230000009467 reduction Effects 0.000 description 7
• 239000004094 surface-active agent Substances 0.000 description 7
• 238000011282 treatment Methods 0.000 description 7
• 102000012422 Collagen Type I Human genes 0.000 description 6
• 108010022452 Collagen Type I Proteins 0.000 description 6
• 230000000735 allogeneic effect Effects 0.000 description 6
• 239000003124 biologic agent Substances 0.000 description 6
• 230000004071 biological effect Effects 0.000 description 6
• 238000001727 in vivo Methods 0.000 description 6
• 208000015181 infectious disease Diseases 0.000 description 6
• 238000010186 staining Methods 0.000 description 6
• 238000001356 surgical procedure Methods 0.000 description 6
• 125000003396 thiol group Chemical group [H]S* 0.000 description 6
• 102000007469 Actins Human genes 0.000 description 5
• 108010085238 Actins Proteins 0.000 description 5
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
• 230000003833 cell viability Effects 0.000 description 5
• 239000002131 composite material Substances 0.000 description 5
• 150000001875 compounds Chemical class 0.000 description 5
• 239000006071 cream Substances 0.000 description 5
• 230000007423 decrease Effects 0.000 description 5
• 239000000975 dye Substances 0.000 description 5
• 238000009472 formulation Methods 0.000 description 5
• 229920001477 hydrophilic polymer Polymers 0.000 description 5
• UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 5
• 208000014674 injury Diseases 0.000 description 5
• 239000006210 lotion Substances 0.000 description 5
• 210000005036 nerve Anatomy 0.000 description 5
• 239000012071 phase Substances 0.000 description 5
• 239000000047 product Substances 0.000 description 5
• 125000001424 substituent group Chemical group 0.000 description 5
• 238000012360 testing method Methods 0.000 description 5
• 230000029663 wound healing Effects 0.000 description 5
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 4
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 4
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 4
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 4
• 208000003251 Pruritus Diseases 0.000 description 4
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 4
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 4
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 4
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 4
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 4
• 238000010521 absorption reaction Methods 0.000 description 4
• 239000000560 biocompatible material Substances 0.000 description 4
• 239000012620 biological material Substances 0.000 description 4
• 230000036760 body temperature Effects 0.000 description 4
• 229940098773 bovine serum albumin Drugs 0.000 description 4
• 230000009087 cell motility Effects 0.000 description 4
• 230000006378 damage Effects 0.000 description 4
• 229940126864 fibroblast growth factor Drugs 0.000 description 4
• 238000011049 filling Methods 0.000 description 4
• 230000009969 flowable effect Effects 0.000 description 4
• 239000006260 foam Substances 0.000 description 4
• 102000034356 gene-regulatory proteins Human genes 0.000 description 4
• 108091006104 gene-regulatory proteins Proteins 0.000 description 4
• 238000002513 implantation Methods 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
• 238000002156 mixing Methods 0.000 description 4
• 239000000178 monomer Substances 0.000 description 4
• 231100000252 nontoxic Toxicity 0.000 description 4
• 230000003000 nontoxic effect Effects 0.000 description 4
• 239000004055 small Interfering RNA Substances 0.000 description 4
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 4
• MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 108010089430 Phosphoproteins Proteins 0.000 description 3
• 102000007982 Phosphoproteins Human genes 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• 235000010443 alginic acid Nutrition 0.000 description 3
• 229920000615 alginic acid Polymers 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 206010003246 arthritis Diseases 0.000 description 3
• 230000003416 augmentation Effects 0.000 description 3
• 210000000481 breast Anatomy 0.000 description 3
• 239000001110 calcium chloride Substances 0.000 description 3
• 229910001628 calcium chloride Inorganic materials 0.000 description 3
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 229940099898 chlorophyllin Drugs 0.000 description 3
• 235000019805 chlorophyllin Nutrition 0.000 description 3
• 238000001212 derivatisation Methods 0.000 description 3
• 201000010099 disease Diseases 0.000 description 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
• 230000000694 effects Effects 0.000 description 3
• 239000003995 emulsifying agent Substances 0.000 description 3
• 239000003205 fragrance Substances 0.000 description 3
• 238000001879 gelation Methods 0.000 description 3
• 230000035876 healing Effects 0.000 description 3
• 210000002216 heart Anatomy 0.000 description 3
• 229940106780 human fibrinogen Drugs 0.000 description 3
• 230000002209 hydrophobic effect Effects 0.000 description 3
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
• 238000000338 in vitro Methods 0.000 description 3
• 238000007917 intracranial administration Methods 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• 238000007913 intrathecal administration Methods 0.000 description 3
• 230000002601 intratumoral effect Effects 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 230000001788 irregular Effects 0.000 description 3
• 210000004379 membrane Anatomy 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 229920005615 natural polymer Polymers 0.000 description 3
• 239000003921 oil Substances 0.000 description 3
• 235000019198 oils Nutrition 0.000 description 3
• 239000006072 paste Substances 0.000 description 3
• 210000002826 placenta Anatomy 0.000 description 3
• 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 3
• 238000006116 polymerization reaction Methods 0.000 description 3
• 238000011069 regeneration method Methods 0.000 description 3
• 210000002460 smooth muscle Anatomy 0.000 description 3
• 230000004083 survival effect Effects 0.000 description 3
• 210000004876 tela submucosa Anatomy 0.000 description 3
• 239000002562 thickening agent Substances 0.000 description 3
• 230000002792 vascular Effects 0.000 description 3
• NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
• 102100036597 Basement membrane-specific heparan sulfate proteoglycan core protein Human genes 0.000 description 2
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 2
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 2
• 102000015225 Connective Tissue Growth Factor Human genes 0.000 description 2
• 108010039419 Connective Tissue Growth Factor Proteins 0.000 description 2
• NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
• 108010071289 Factor XIII Proteins 0.000 description 2
• 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 2
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 2
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical group NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
• 102100031000 Hepatoma-derived growth factor Human genes 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101001083798 Homo sapiens Hepatoma-derived growth factor Proteins 0.000 description 2
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
• 102000015696 Interleukins Human genes 0.000 description 2
• 108010063738 Interleukins Proteins 0.000 description 2
• UILOTUUZKGTYFQ-UHFFFAOYSA-N Mafenide acetate Chemical compound CC(O)=O.NCC1=CC=C(S(N)(=O)=O)C=C1 UILOTUUZKGTYFQ-UHFFFAOYSA-N 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
• 108010025020 Nerve Growth Factor Proteins 0.000 description 2
• 102000015336 Nerve Growth Factor Human genes 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 108010022999 Serine Proteases Proteins 0.000 description 2
• 102000012479 Serine Proteases Human genes 0.000 description 2
• FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 2
• 208000026137 Soft tissue injury Diseases 0.000 description 2
• 102000013275 Somatomedins Human genes 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
• 239000005844 Thymol Substances 0.000 description 2
• 230000000996 additive effect Effects 0.000 description 2
• 238000013019 agitation Methods 0.000 description 2
• 150000001299 aldehydes Chemical class 0.000 description 2
• 229940072056 alginate Drugs 0.000 description 2
• 125000000129 anionic group Chemical group 0.000 description 2
• 230000002924 anti-infective effect Effects 0.000 description 2
• 239000002260 anti-inflammatory agent Substances 0.000 description 2
• 229940121363 anti-inflammatory agent Drugs 0.000 description 2
• 229940064004 antiseptic throat preparations Drugs 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 150000004283 biguanides Chemical class 0.000 description 2
• 239000000227 bioadhesive Substances 0.000 description 2
• 210000000988 bone and bone Anatomy 0.000 description 2
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 210000004413 cardiac myocyte Anatomy 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 239000000812 cholinergic antagonist Substances 0.000 description 2
• 229960002227 clindamycin Drugs 0.000 description 2
• KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 2
• 230000035602 clotting Effects 0.000 description 2
• 238000013270 controlled release Methods 0.000 description 2
• 239000013256 coordination polymer Substances 0.000 description 2
• 238000002316 cosmetic surgery Methods 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 239000008367 deionised water Substances 0.000 description 2
• 229910021641 deionized water Inorganic materials 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 210000004207 dermis Anatomy 0.000 description 2
• 230000005489 elastic deformation Effects 0.000 description 2
• 230000001747 exhibiting effect Effects 0.000 description 2
• 229940012444 factor xiii Drugs 0.000 description 2
• 210000003195 fascia Anatomy 0.000 description 2
• 239000007863 gel particle Substances 0.000 description 2
• 239000003349 gelling agent Substances 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
• 230000000887 hydrating effect Effects 0.000 description 2
• 239000012678 infectious agent Substances 0.000 description 2
• 230000008595 infiltration Effects 0.000 description 2
• 238000001764 infiltration Methods 0.000 description 2
• 239000007972 injectable composition Substances 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 150000002515 isoflavone derivatives Chemical class 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 238000011068 loading method Methods 0.000 description 2
• 229960002721 mafenide acetate Drugs 0.000 description 2
• 229940041616 menthol Drugs 0.000 description 2
• 229960000282 metronidazole Drugs 0.000 description 2
• VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
• 230000000813 microbial effect Effects 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 201000003152 motion sickness Diseases 0.000 description 2
• 229940053128 nerve growth factor Drugs 0.000 description 2
• 230000002981 neuropathic effect Effects 0.000 description 2
• AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
• 150000002905 orthoesters Chemical class 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• 210000000496 pancreas Anatomy 0.000 description 2
• 108010049224 perlecan Proteins 0.000 description 2
• 239000008194 pharmaceutical composition Substances 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 230000000704 physical effect Effects 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229920001296 polysiloxane Polymers 0.000 description 2
• 230000035755 proliferation Effects 0.000 description 2
• 238000010526 radical polymerization reaction Methods 0.000 description 2
• 230000001603 reducing effect Effects 0.000 description 2
• 230000008929 regeneration Effects 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 239000000565 sealant Substances 0.000 description 2
• SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
• 210000002027 skeletal muscle Anatomy 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 210000000278 spinal cord Anatomy 0.000 description 2
• 239000007921 spray Substances 0.000 description 2
• 230000003068 static effect Effects 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 230000008961 swelling Effects 0.000 description 2
• 239000011206 ternary composite Substances 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 229960000790 thymol Drugs 0.000 description 2
• 230000007838 tissue remodeling Effects 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• 230000008733 trauma Effects 0.000 description 2
• 210000003954 umbilical cord Anatomy 0.000 description 2
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
• 235000013311 vegetables Nutrition 0.000 description 2
• ZJIFDEVVTPEXDL-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) hydrogen carbonate Chemical compound OC(=O)ON1C(=O)CCC1=O ZJIFDEVVTPEXDL-UHFFFAOYSA-N 0.000 description 1
• 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
• DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
• CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
• WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
• SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
• FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 1
• SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 1
• IHDBZCJYSHDCKF-UHFFFAOYSA-N 4,6-dichlorotriazine Chemical compound ClC1=CC(Cl)=NN=N1 IHDBZCJYSHDCKF-UHFFFAOYSA-N 0.000 description 1
• QXZGLTYKKZKGLN-UHFFFAOYSA-N 4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)ON1C(=O)CCC1=O QXZGLTYKKZKGLN-UHFFFAOYSA-N 0.000 description 1
• OFNXOACBUMGOPC-HZYVHMACSA-N 5'-hydroxystreptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](CO)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O OFNXOACBUMGOPC-HZYVHMACSA-N 0.000 description 1
• NWAGXLBTAPTCPR-UHFFFAOYSA-N 5-(2,5-dioxopyrrolidin-1-yl)oxy-5-oxopentanoic acid Chemical compound OC(=O)CCCC(=O)ON1C(=O)CCC1=O NWAGXLBTAPTCPR-UHFFFAOYSA-N 0.000 description 1
• GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
• 101150079978 AGRN gene Proteins 0.000 description 1
• HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 102100036601 Aggrecan core protein Human genes 0.000 description 1
• 108010067219 Aggrecans Proteins 0.000 description 1
• 102100040026 Agrin Human genes 0.000 description 1
• 108700019743 Agrin Proteins 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 102000004954 Biglycan Human genes 0.000 description 1
• 108090001138 Biglycan Proteins 0.000 description 1
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
• 206010006803 Burns third degree Diseases 0.000 description 1
• 102000000905 Cadherin Human genes 0.000 description 1
• 108050007957 Cadherin Proteins 0.000 description 1
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
• LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
• 241000723346 Cinnamomum camphora Species 0.000 description 1
• 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
• 235000005979 Citrus limon Nutrition 0.000 description 1
• 244000131522 Citrus pyriformis Species 0.000 description 1
• 206010053567 Coagulopathies Diseases 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 235000005956 Cosmos caudatus Nutrition 0.000 description 1
• 239000004971 Cross linker Substances 0.000 description 1
• 244000301850 Cupressus sempervirens Species 0.000 description 1
• 240000004784 Cymbopogon citratus Species 0.000 description 1
• 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
• 244000166675 Cymbopogon nardus Species 0.000 description 1
• 235000018791 Cymbopogon nardus Nutrition 0.000 description 1
• 102000004237 Decorin Human genes 0.000 description 1
• 108090000738 Decorin Proteins 0.000 description 1
• 208000008960 Diabetic foot Diseases 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 1
• 206010013530 Diverticula Diseases 0.000 description 1
• 206010013554 Diverticulum Diseases 0.000 description 1
• 240000002943 Elettaria cardamomum Species 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 108091013881 Epiphycan Proteins 0.000 description 1
• 102000027313 Epiphycan Human genes 0.000 description 1
• 239000004593 Epoxy Substances 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 208000010228 Erectile Dysfunction Diseases 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
• IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
• 239000005977 Ethylene Substances 0.000 description 1
• IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
• WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
• 244000004281 Eucalyptus maculata Species 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 206010049290 Feminisation acquired Diseases 0.000 description 1
• 208000034793 Feminization Diseases 0.000 description 1
• 102000017177 Fibromodulin Human genes 0.000 description 1
• 108010013996 Fibromodulin Proteins 0.000 description 1
• 241000192125 Firmicutes Species 0.000 description 1
• 206010016717 Fistula Diseases 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 240000001238 Gaultheria procumbens Species 0.000 description 1
• 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
• 241000208152 Geranium Species 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 102000001554 Hemoglobins Human genes 0.000 description 1
• 208000031220 Hemophilia Diseases 0.000 description 1
• 208000009292 Hemophilia A Diseases 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 206010019909 Hernia Diseases 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 241000721662 Juniperus Species 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• 235000013628 Lantana involucrata Nutrition 0.000 description 1
• 240000005183 Lantana involucrata Species 0.000 description 1
• 244000165082 Lavanda vera Species 0.000 description 1
• 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
• 102100032114 Lumican Human genes 0.000 description 1
• 108010076371 Lumican Proteins 0.000 description 1
• 235000015459 Lycium barbarum Nutrition 0.000 description 1
• PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
• 235000006679 Mentha X verticillata Nutrition 0.000 description 1
• 235000014749 Mentha crispa Nutrition 0.000 description 1
• 244000246386 Mentha pulegium Species 0.000 description 1
• 235000016257 Mentha pulegium Nutrition 0.000 description 1
• 244000078639 Mentha spicata Species 0.000 description 1
• 235000002899 Mentha suaveolens Nutrition 0.000 description 1
• 235000004357 Mentha x piperita Nutrition 0.000 description 1
• 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
• 229920003095 Methocel™ K15M Polymers 0.000 description 1
• 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
• 244000179970 Monarda didyma Species 0.000 description 1
• 235000010672 Monarda didyma Nutrition 0.000 description 1
• 235000009421 Myristica fragrans Nutrition 0.000 description 1
• 244000270834 Myristica fragrans Species 0.000 description 1
• 102100037369 Nidogen-1 Human genes 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 108091006006 PEGylated Proteins Proteins 0.000 description 1
• 241001504519 Papio ursinus Species 0.000 description 1
• 108010066305 Parkinson Disease Associated Proteins Proteins 0.000 description 1
• 102000018315 Parkinson Disease Associated Proteins Human genes 0.000 description 1
• 206010034133 Pathogen resistance Diseases 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 241000218657 Picea Species 0.000 description 1
• 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
• 241000018646 Pinus brutia Species 0.000 description 1
• 235000011613 Pinus brutia Nutrition 0.000 description 1
• 239000004721 Polyphenylene oxide Substances 0.000 description 1
• NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 108010081750 Reticulin Proteins 0.000 description 1
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
• 241000220317 Rosa Species 0.000 description 1
• 240000000513 Santalum album Species 0.000 description 1
• 235000008632 Santalum album Nutrition 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 229920002385 Sodium hyaluronate Polymers 0.000 description 1
• 102000005890 Spectrin Human genes 0.000 description 1
• 108010019965 Spectrin Proteins 0.000 description 1
• 206010041541 Spinal compression fracture Diseases 0.000 description 1
• 206010041925 Staphylococcal infections Diseases 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 244000223014 Syzygium aromaticum Species 0.000 description 1
• 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
• GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
• 208000031737 Tissue Adhesions Diseases 0.000 description 1
• 235000009499 Vanilla fragrans Nutrition 0.000 description 1
• 244000263375 Vanilla tahitensis Species 0.000 description 1
• 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 108010031318 Vitronectin Proteins 0.000 description 1
• 102100035140 Vitronectin Human genes 0.000 description 1
• 206010053692 Wound complication Diseases 0.000 description 1
• 206010048038 Wound infection Diseases 0.000 description 1
• 210000001015 abdomen Anatomy 0.000 description 1
• 210000000579 abdominal fat Anatomy 0.000 description 1
• 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 238000004220 aggregation Methods 0.000 description 1
• 229940050528 albumin Drugs 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 1
• 150000001336 alkenes Chemical class 0.000 description 1
• 239000000921 anthelmintic agent Substances 0.000 description 1
• 229940124339 anthelmintic agent Drugs 0.000 description 1
• 239000000058 anti acne agent Substances 0.000 description 1
• 230000001078 anti-cholinergic effect Effects 0.000 description 1
• 229940127003 anti-diabetic drug Drugs 0.000 description 1
• 230000001387 anti-histamine Effects 0.000 description 1
• 230000003110 anti-inflammatory effect Effects 0.000 description 1
• 230000002141 anti-parasite Effects 0.000 description 1
• 230000003356 anti-rheumatic effect Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 229940124340 antiacne agent Drugs 0.000 description 1
• 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
• 229940124345 antianginal agent Drugs 0.000 description 1
• 229940124347 antiarthritic drug Drugs 0.000 description 1
• 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
• 239000003472 antidiabetic agent Substances 0.000 description 1
• 229940125715 antihistaminic agent Drugs 0.000 description 1
• 239000003434 antitussive agent Substances 0.000 description 1
• 229940121357 antivirals Drugs 0.000 description 1
• 229920006187 aquazol Polymers 0.000 description 1
• 239000012861 aquazol Substances 0.000 description 1
• 239000008365 aqueous carrier Substances 0.000 description 1
• 239000008346 aqueous phase Substances 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• 235000019568 aromas Nutrition 0.000 description 1
• 125000004429 atom Chemical group 0.000 description 1
• 150000001540 azides Chemical class 0.000 description 1
• OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
• 230000003796 beauty Effects 0.000 description 1
• 239000003139 biocide Substances 0.000 description 1
• 229920000249 biocompatible polymer Polymers 0.000 description 1
• 230000032770 biofilm formation Effects 0.000 description 1
• 239000003114 blood coagulation factor Substances 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
• BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 1
• 229960000846 camphor Drugs 0.000 description 1
• 229930008380 camphor Natural products 0.000 description 1
• 150000001718 carbodiimides Chemical class 0.000 description 1
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
• PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
• 235000005300 cardamomo Nutrition 0.000 description 1
• 229940125692 cardiovascular agent Drugs 0.000 description 1
• 239000003054 catalyst Substances 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 210000003855 cell nucleus Anatomy 0.000 description 1
• 238000001516 cell proliferation assay Methods 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000010382 chemical cross-linking Methods 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 229940045110 chitosan Drugs 0.000 description 1
• ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical class C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
• 210000001136 chorion Anatomy 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 229960005233 cineole Drugs 0.000 description 1
• 235000017803 cinnamon Nutrition 0.000 description 1
• 230000037369 collagen remodeling Effects 0.000 description 1
• 230000006835 compression Effects 0.000 description 1
• 238000007906 compression Methods 0.000 description 1
• 230000002254 contraceptive effect Effects 0.000 description 1
• 230000008602 contraction Effects 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 210000004087 cornea Anatomy 0.000 description 1
• 238000012937 correction Methods 0.000 description 1
• 239000002537 cosmetic Substances 0.000 description 1
• 229920006037 cross link polymer Polymers 0.000 description 1
• 208000031513 cyst Diseases 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 229920006237 degradable polymer Polymers 0.000 description 1
• 239000007857 degradation product Substances 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000009792 diffusion process Methods 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 150000002009 diols Chemical group 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 150000002027 dodecanoic acid esters Chemical class 0.000 description 1
• UWLPCYBIJSLGQO-UHFFFAOYSA-N dodecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCC(O)=O UWLPCYBIJSLGQO-UHFFFAOYSA-N 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• 150000002118 epoxides Chemical class 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 239000002350 fibrinopeptide Substances 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 230000003890 fistula Effects 0.000 description 1
• 238000002073 fluorescence micrograph Methods 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 235000011187 glycerol Nutrition 0.000 description 1
• 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 230000004217 heart function Effects 0.000 description 1
• 210000003709 heart valve Anatomy 0.000 description 1
• 230000002008 hemorrhagic effect Effects 0.000 description 1
• 230000002439 hemostatic effect Effects 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 239000012456 homogeneous solution Substances 0.000 description 1
• 238000000265 homogenisation Methods 0.000 description 1
• 235000001050 hortel pimenta Nutrition 0.000 description 1
• 150000004677 hydrates Chemical class 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 150000002433 hydrophilic molecules Chemical class 0.000 description 1
• OFNXOACBUMGOPC-UHFFFAOYSA-N hydroxystreptomycin Natural products CNC1C(O)C(O)C(CO)OC1OC1C(C=O)(O)C(CO)OC1OC1C(N=C(N)N)C(O)C(N=C(N)N)C(O)C1O OFNXOACBUMGOPC-UHFFFAOYSA-N 0.000 description 1
• 125000002883 imidazolyl group Chemical group 0.000 description 1
• 125000001841 imino group Chemical group [H]N=* 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 201000001881 impotence Diseases 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 238000010952 in-situ formation Methods 0.000 description 1
• 125000001041 indolyl group Chemical group 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 239000003999 initiator Substances 0.000 description 1
• 238000009434 installation Methods 0.000 description 1
• PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 239000012948 isocyanate Substances 0.000 description 1
• 150000002513 isocyanates Chemical class 0.000 description 1
• OKPOKMCPHKVCPP-UHFFFAOYSA-N isoorientaline Natural products C1=C(O)C(OC)=CC(CC2C3=CC(OC)=C(O)C=C3CCN2C)=C1 OKPOKMCPHKVCPP-UHFFFAOYSA-N 0.000 description 1
• 150000002540 isothiocyanates Chemical class 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 210000002429 large intestine Anatomy 0.000 description 1
• 239000001102 lavandula vera Substances 0.000 description 1
• 235000018219 lavender Nutrition 0.000 description 1
• 210000003041 ligament Anatomy 0.000 description 1
• 229930007744 linalool Natural products 0.000 description 1
• 239000007791 liquid phase Substances 0.000 description 1
• 210000005229 liver cell Anatomy 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 238000002803 maceration Methods 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 108010082117 matrigel Proteins 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
• 229960001047 methyl salicylate Drugs 0.000 description 1
• 239000011325 microbead Substances 0.000 description 1
• 238000002406 microsurgery Methods 0.000 description 1
• 210000004088 microvessel Anatomy 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 230000001002 morphogenetic effect Effects 0.000 description 1
• 210000000214 mouth Anatomy 0.000 description 1
• 230000002107 myocardial effect Effects 0.000 description 1
• UUIQMZJEGPQKFD-UHFFFAOYSA-N n-butyric acid methyl ester Natural products CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 1
• QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
• 229940000041 nervous system drug Drugs 0.000 description 1
• 108010008217 nidogen Proteins 0.000 description 1
• 150000004767 nitrides Chemical class 0.000 description 1
• OKXGHXHZNCJMSV-UHFFFAOYSA-N nitro phenyl carbonate Chemical compound [O-][N+](=O)OC(=O)OC1=CC=CC=C1 OKXGHXHZNCJMSV-UHFFFAOYSA-N 0.000 description 1
• 238000012758 nuclear staining Methods 0.000 description 1
• 239000001702 nutmeg Substances 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Chemical class 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• YTSACTNRGUJEGO-UHFFFAOYSA-N oxirane prop-1-ene Chemical group CC=C.C1CO1 YTSACTNRGUJEGO-UHFFFAOYSA-N 0.000 description 1
• 150000002942 palmitic acid derivatives Chemical class 0.000 description 1
• 230000002445 parasympatholytic effect Effects 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 239000002304 perfume Substances 0.000 description 1
• 210000003516 pericardium Anatomy 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 230000010399 physical interaction Effects 0.000 description 1
• 239000000049 pigment Substances 0.000 description 1
• 239000010665 pine oil Substances 0.000 description 1
• 239000004014 plasticizer Substances 0.000 description 1
• 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
• 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 1
• 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
• 229920000570 polyether Polymers 0.000 description 1
• 239000004633 polyglycolic acid Substances 0.000 description 1
• 229920000903 polyhydroxyalkanoate Polymers 0.000 description 1
• 239000004926 polymethyl methacrylate Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 239000000955 prescription drug Substances 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 238000007348 radical reaction Methods 0.000 description 1
• 239000012857 radioactive material Substances 0.000 description 1
• 230000035484 reaction time Effects 0.000 description 1
• 238000002278 reconstructive surgery Methods 0.000 description 1
• 230000001172 regenerating effect Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000003014 reinforcing effect Effects 0.000 description 1
• 230000003716 rejuvenation Effects 0.000 description 1
• 230000002940 repellent Effects 0.000 description 1
• 239000005871 repellent Substances 0.000 description 1
• JTQHYPFKHZLTSH-UHFFFAOYSA-N reticulin Natural products COC1CC(OC2C(CO)OC(OC3C(O)CC(OC4C(C)OC(CC4OC)OC5CCC6(C)C7CCC8(C)C(CCC8(O)C7CC=C6C5)C(C)O)OC3C)C(O)C2OC)OC(C)C1O JTQHYPFKHZLTSH-UHFFFAOYSA-N 0.000 description 1
• 150000004492 retinoid derivatives Chemical class 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 239000010671 sandalwood oil Substances 0.000 description 1
• 231100000241 scar Toxicity 0.000 description 1
• 238000007789 sealing Methods 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 238000007873 sieving Methods 0.000 description 1
• 229910001961 silver nitrate Inorganic materials 0.000 description 1
• 229940010747 sodium hyaluronate Drugs 0.000 description 1
• YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
• 230000003381 solubilizing effect Effects 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 239000012798 spherical particle Substances 0.000 description 1
• 230000007480 spreading Effects 0.000 description 1
• 238000003892 spreading Methods 0.000 description 1
• 239000012128 staining reagent Substances 0.000 description 1
• 229910001220 stainless steel Inorganic materials 0.000 description 1
• 239000010935 stainless steel Substances 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 238000005728 strengthening Methods 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 230000002522 swelling effect Effects 0.000 description 1
• 210000001258 synovial membrane Anatomy 0.000 description 1
• IMCGHZIGRANKHV-AJNGGQMLSA-N tert-butyl (3s,5s)-2-oxo-5-[(2s,4s)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate Chemical compound O1C(=O)[C@H](C(C)C)C[C@H]1[C@H]1N(C(=O)OC(C)(C)C)C(=O)[C@H](C(C)C)C1 IMCGHZIGRANKHV-AJNGGQMLSA-N 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 230000009974 thixotropic effect Effects 0.000 description 1
• 229960003766 thrombin (human) Drugs 0.000 description 1
• 230000009772 tissue formation Effects 0.000 description 1
• 230000008467 tissue growth Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 230000000472 traumatic effect Effects 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 229940124543 ultraviolet light absorber Drugs 0.000 description 1
• 210000003932 urinary bladder Anatomy 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 229920002554 vinyl polymer Polymers 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 108010047303 von Willebrand Factor Proteins 0.000 description 1
• 102100036537 von Willebrand factor Human genes 0.000 description 1
• 229960001134 von willebrand factor Drugs 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 239000009637 wintergreen oil Substances 0.000 description 1
• 230000037303 wrinkles Effects 0.000 description 1